Skip to main content
Livermore
Livermore
ZHEN

Beryl Capital Management LLC

SEC CIK
0001719307
Latest filing
Aug 14, 2026

The latest 13F from Beryl Capital Management LLC covers Q2 2026 (filed Aug 14, 2026): 7 long positions worth $110.7M. The top 10 holdings make up 100.0% of the portfolio, and the largest is Janus Henderson Group Ltd. (JHG) at 66.4%. Livermore has 23 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
7
Est. +$110.7M
Added
0
Reduced
0
Sold out
8
Est. −$108.6M

Top 5 holdings

Share of this quarter's portfolio value

  1. JHGJanus Henderson Group Ltd.
    66.4%$73.5MHistory
  2. ESPREsperion Therapeutics, Inc.
    12.7%$14.0MHistory
  3. APGEApogee Therapeutics, Inc.
    7.0%$7.79MHistory
  4. SILASila Realty Trust, Inc.
    5.5%$6.07MHistory
  5. AVNSAvanos Medical, Inc.
    3.5%$3.86MHistory

Share of portfolio

Top 5 holdings and the other 2 positions, by share of portfolio value

  1. JHG66.4%
  2. ESPR12.7%
  3. APGE7.0%
  4. SILA5.5%
  5. AVNS3.5%
  6. Other 2 positions4.9%

Biggest buys

New and added positions, by estimated amount bought

  1. JHGJanus Henderson Group Ltd.
    +$73.5MNewHistory
  2. ESPREsperion Therapeutics, Inc.
    +$14.0MNewHistory
  3. APGEApogee Therapeutics, Inc.
    +$7.79MNewHistory
  4. SILASila Realty Trust, Inc.
    +$6.07MNewHistory
  5. AVNSAvanos Medical, Inc.
    +$3.86MNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. JHGJanus Henderson Group Ltd.
    +66.44 pp0.0% → 66.4%History
  2. ESPREsperion Therapeutics, Inc.
    +12.65 pp0.0% → 12.7%History
  3. APGEApogee Therapeutics, Inc.
    +7.04 pp0.0% → 7.0%History
  4. SILASila Realty Trust, Inc.
    +5.49 pp0.0% → 5.5%History
  5. AVNSAvanos Medical, Inc.
    +3.49 pp0.0% → 3.5%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. MASIMasimo Corp
    −$38.6MSold outHistory
  2. TERNTerns Pharmaceuticals, Inc.
    −$25.2MSold outHistory
  3. GLDDGreat Lakes Dredge & Dock CORP
    −$15.5MSold outHistory
  4. DAWNDay One Biopharmaceuticals, Inc.
    −$11.0MSold outHistory
  5. STKLSunOpta Inc.
    −$9.77MSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. MASIMasimo Corp
    −35.54 pp35.5% → 0.0%History
  2. TERNTerns Pharmaceuticals, Inc.
    −23.23 pp23.2% → 0.0%History
  3. GLDDGreat Lakes Dredge & Dock CORP
    −14.28 pp14.3% → 0.0%History
  4. DAWNDay One Biopharmaceuticals, Inc.
    −10.15 pp10.1% → 0.0%History
  5. STKLSunOpta Inc.
    −9.00 pp9.0% → 0.0%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$110.7M
+$2.02M (+1.9%) vs. prior quarter
Positions
7
−1 vs. prior quarter
Top 10 concentration
100.0%
Top 10 as share of value
Turnover
99.1%
Q2 2026, one quarter
Average holding period
1.0 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $1.94B (Q4 2021)

Q1 2021: $777.8MQ2 2021: $1.12BQ3 2021: $1.42BQ4 2021: $1.94BQ1 2022: $1.65BQ2 2022: $967.5MQ3 2022: $942.2MQ4 2022: $248.5MQ1 2023: $119.7MQ2 2023: $324.1MQ3 2023: $786.6MQ4 2023: $182.1MQ1 2024: $82.0MQ2 2024: $332.6MQ3 2024: $463.0MQ4 2024: $442.6MQ1 2025: $267.7MQ2 2025: $664.0MQ3 2025: $52.0MQ4 2025: $986.3MQ1 2026: $108.6MQ2 2026: $110.7M
Q1 2021Q2 2026
13F filings of Beryl Capital Management LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 20267$110.7MJHGESPRAPGEvs. Q1 2026SEC
Q1 2026May 15, 20268$108.6MMASITERNGLDDvs. Q4 2025SEC
Q4 2025Feb 17, 202615$986.3MEXASCFLTDAYvs. Q3 2025SEC
Q3 2025Nov 14, 20256$52.0MCLSKUNHBTDRvs. Q2 2025SEC
Q2 2025Aug 14, 202528$664.0MBPMCSKXSWTXvs. Q1 2025SEC
Q1 2025May 15, 202513$267.7MITCIBECNCMRXvs. Q4 2024SEC
Q4 2024Feb 14, 202531$442.6MCORZBCOVRVNCvs. Q3 2024SEC
Q3 2024Nov 14, 202430$463.0MCORZSMARSRDXvs. Q2 2024SEC
Q2 2024Aug 14, 202424$332.6MCORZSRDXPWSCvs. Q1 2024SEC
Q1 2024May 15, 202418$82.0MCTLTFREESCTLvs. Q4 2023SEC
Q4 2023Feb 14, 202420$182.1MSPLKAYXORTXvs. Q3 2023SEC
Q3 2023Nov 14, 202330$786.6MHZNPVMWATVIvs. Q2 2023SEC
Q2 2023Aug 14, 202317$324.1MISEESIMOACIvs. Q1 2023SEC
Q1 2023May 15, 202316$119.7MACINewHold Investment Corp. IICFFSvs. Q4 2022SEC
Q4 2022Feb 14, 202323$248.5MSJIForest Road Acquisition CorEpiphany Technology Acquisitvs. Q3 2022SEC
Q3 2022Nov 14, 202228$942.2MAVLRTWTRZENvs. Q2 2022SEC
Q2 2022Aug 15, 202253$967.5MCDKSailpoint Technologies Holdings, Inc.CTXSvs. Q1 2022SEC
Q1 2022May 16, 2022254$1.65BCFIVQueens Gambit Growth CapitalPLANvs. Q4 2021SEC
Q4 2021Mar 15, 2022Amended374$1.94BTrebia Acquisition CorpM3-Brigade Acquisition II Corp.GCT Semiconductor Holding, Inc.vs. Q3 2021SEC
Q3 2021Nov 15, 2021220$1.42BSTMPJWSMFCCVIvs. Q2 2021SEC
Q2 2021Aug 16, 2021189$1.12BALXNPFPTJWSMFvs. Q1 2021SEC
Q1 2021May 17, 2021203$777.8MPerspecta IncMichaels Cos IncPluralsight Inc–SEC

13D and 13G filings

Companies where Beryl Capital Management LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

Beryl Capital Management LLC does not currently report owning 5% or more of any company.

Latest filings

323 filings on file made by Beryl Capital Management LLC or listing it as a reporting person; the latest 20 are shown.

Schedule 13D and 13G filings by Beryl Capital Management LLC
CompanyFiled (ET)FormStakeChangeEvent dateFiling
ULYXUrgent.ly Inc.Jul 6, 20265:12 PM ET13G/A0.00%0 shares−9.10 ppfrom 9.10%Below 5%Jun 30, 2026SEC
ULYXUrgent.ly Inc.Mar 23, 20264:00 PM ET13G9.10%200.0K sharesNewMar 16, 2026SEC
YMABY-mAbs Therapeutics, Inc.Nov 14, 20252:33 PM ET13G/A0.00%0 shares−9.00 ppfrom 9.00%Below 5%Sep 30, 2025SEC
VIGLVigil Neuroscience, Inc.Nov 14, 20252:32 PM ET13G/A0.00%0 shares−9.90 ppfrom 9.90%Below 5%Sep 30, 2025SEC
STRMStreamline Health Solutions Inc.Nov 14, 20252:30 PM ET13G/A0.00%0 shares−8.60 ppfrom 8.60%Below 5%Sep 30, 2025SEC
SGMASigmatron International IncNov 14, 20252:29 PM ET13G/A0.00%0 shares−9.70 ppfrom 9.70%Below 5%Sep 30, 2025SEC
ENZBEnzo Biochem IncNov 14, 20252:27 PM ET13G/A0.00%0 shares−9.70 ppfrom 9.70%Below 5%Sep 30, 2025SEC
DALNDallasNews CorpNov 14, 20252:23 PM ET13G/A0.00%0 shares−9.90 ppfrom 9.90%Below 5%Sep 30, 2025SEC
TSVT2seventy bio, Inc.Aug 14, 202512:48 PM ET13G/A0.00%0 shares−8.10 ppfrom 8.10%Below 5%Jun 30, 2025SEC
PHXPHX Minerals Inc.Aug 14, 202512:46 PM ET13G/A0.00%0 shares−8.90 ppfrom 8.90%Below 5%Jun 30, 2025SEC
NVRONevro CorpAug 14, 202512:44 PM ET13G/A0.00%0 shares−6.50 ppfrom 6.50%Below 5%Jun 30, 2025SEC
INZYInozyme Pharma, Inc.Aug 14, 202512:38 PM ET13G/A0.00%0 shares−9.80 ppfrom 9.80%Below 5%Jun 30, 2025SEC
CKPTCheckpoint Therapeutics, Inc.Aug 14, 202512:34 PM ET13G/A0.00%0 shares−9.90 ppfrom 9.90%Below 5%Jun 30, 2025SEC
ALLKAllakos Inc.Aug 14, 202512:31 PM ET13G/A0.00%0 shares−8.90 ppfrom 8.90%Below 5%Jun 30, 2025SEC
YMABY-mAbs Therapeutics, Inc.Aug 12, 20254:16 PM ET13G9.00%4.09M sharesNewAug 5, 2025SEC
DALNDallasNews CorpJul 22, 20254:02 PM ET13G9.90%470.3K sharesNewJul 15, 2025SEC
ENZBEnzo Biochem IncJul 1, 20255:55 PM ET13G9.70%5.07M sharesNewJun 24, 2025SEC
STRMStreamline Health Solutions Inc.Jun 5, 20258:26 PM ET13G8.60%374.0K sharesNewMay 29, 2025SEC
VIGLVigil Neuroscience, Inc.May 30, 20255:04 PM ET13G9.90%4.61M sharesNewMay 22, 2025SEC
SGMASigmatron International IncMay 29, 20253:31 PM ET13G9.70%590.9K sharesNewMay 21, 2025SEC